Literature DB >> 11979380

Invasive papillary adenocarcinoma of the colon.

Juan P Palazzo1, Tina Bocker Edmonston, Linda M Chaille-Arnold, Susan Burkholder.   

Abstract

Colonic adenocarcinomas are among the most common type of tumors. In this report, we present the morphologic, immunohistochemical, and microsatellite findings of 2 cases with a distinct invasive papillary component. Both tumors arose from polyps in middle-aged patients, followed an aggressive course, and showed a superficial adenomatous component. The immunohistochemical stains showed that the tumor cells were negative for p27 and p53; both tumors were microsatellite stable, that is, with no microsatellite instability in the 6 markers studied, and there was no loss of the mismatch repair proteins hMSH2 or hMLH1. These findings suggest that these tumors follow the tumor-suppressor pathway and represent an aggressive subtype of colonic adenocarcinoma. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979380     DOI: 10.1053/hupa.2002.32228

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Adenoma-like adenocarcinoma: a subtype of colorectal carcinoma with good prognosis, deceptive appearance on biopsy and frequent KRAS mutation.

Authors:  Raul S Gonzalez; Justin M M Cates; Mary Kay Washington; Robert Daniel Beauchamp; Robert J Coffey; Chanjuan Shi
Journal:  Histopathology       Date:  2015-06-04       Impact factor: 5.087

2.  Analysis of mtDNA sequence variants in colorectal adenomatous polyps.

Authors:  Sharifeh Mehrabi; Joyce A Akwe; Gregory Adams; William Grizzle; Xuebiao Yao; Felix O Aikhionbare
Journal:  Diagn Pathol       Date:  2010-10-07       Impact factor: 2.644

3.  Adenoma-like adenocarcinoma: clinicopathologic characterization of a newly recognized subtype of colorectal carcinoma.

Authors:  Iván A González; Philip S Bauer; Jingxia Liu; Deyali Chatterjee
Journal:  Hum Pathol       Date:  2020-09-28       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.